Back to Mednaro
MEDNARO HEALTH
Mednaro’s website describes planned clinician-guided care. Treatment decisions require individual evaluation.
Prescription medications can have contraindications, interactions, side effects and monitoring requirements. The appropriate option depends on personal medical history, current medications, laboratory data when relevant and clinician judgment.
Some uses discussed on the site may be off-label. Off-label use means an FDA-approved medication is being considered for a use, population, dose or route not specifically included in its FDA-approved labeling. Off-label treatment is not appropriate for everyone.
GLP-1 medicines, hormone therapies, erectile-dysfunction medicines, hair-loss treatments, prescription skin treatments and healthy-aging pathways each have distinct safety considerations. No medication is guaranteed and no result is promised.
Rapamycin (sirolimus) has FDA-approved medical uses; use for healthy aging is off-label, and benefits for longevity or body composition are not established.
Do not use Mednaro for emergencies. Call 911 or seek emergency care for severe or rapidly worsening symptoms, chest pain, severe shortness of breath, signs of stroke, severe allergic reaction, suicidal intent or another potentially life-threatening condition.
Effective September 29, 2026